https://www.selleckchem.com/pr....oducts/tunicamycin.h
The current study describes the spectrum of community-acquired respiratory infections (CARV) during the first year after lung transplantation (LT). Additionally, we elucidate variables associated with CARV, management strategies utilized, and impact on early and late outcomes. This was a retrospective study among patients transplanted between 2012 and 2015 (n=255, mean age 55.6±13.5years, M F 152103). The diagnosis of CARV was based on the multiplex PCR on nasopharyngeal swab samples. Baseline characteristics, post-transplant variab
Like
Comment
Share
